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Hedi Hegyi1,2Abstract: Schizophrenia is a complex disease with uncertain aetiology. We suggest GABBR1, GABA receptor B1
implicated in schizophrenia based on a HERV-W LTR in the regulatory region of GABBR1. Our hypothesis is supported
by: (i) GABBR1 is in the 6p22 genomic region most often implicated in schizophrenia; (ii) microarray studies found that
only presynaptic pathway-related genes, including GABA receptors, have altered expression in schizophrenic patients
and (iii) it explains how HERV-W elements, expressed in schizophrenia, play a role in the disease: by altering the
expression of GABBR1 via a long terminal repeat that is also a regulatory element to GABBR1.
Reviewers: This paper was reviewed by Sandor Pongor and Martijn Huynen.
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Schizophrenia is a devastating psychiatric disorder with a
strong genetic component (with an estimated 80-85% herit-
ability [1]) affecting approximately 1% of the population.
Despite intensive research in the past decades there is still
no known cause of the disease that would account for the
majority of the cases. Several systematic studies have been
conducted that implicated various genes in the aetiology of
schizophrenia (in Genecards [2], a comprehensive knowl-
edgebase of all human genes, more than 1600 genes are
annotated to have some association with schizophrenia),
however only a few of them are considered susceptibility
genes [1,3]. In a meta-analysis of more than 8000
European-ancestry subjects significant association with
schizophrenia was observed in a region of linkage disequi-
librium on chromosome 6p22.1, a region that has been
commonly implicated in schizophrenia for a long time [4].
A comprehensive microarray expression profiling of
the prefrontal cortex pinpointed a group of genes with
abnormal expression [5]. Mirnics et al. found that out of
250 gene groups only genes in the presynaptic pathway
showed an altered expression [5]. This is in line with the
findings of other groups, calling schizophrenia the
disease of the synapse [6].Correspondence: hegyihedi@gmail.com
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reproduction in any medium, provided the orIn a different approach, mostly subscribed to the
hypothesis of viral origin of schizophrenia, several groups
found a marked expression of human endogenous
retroviruses, mostly the HERV-W subtype being expressed
in patients with recent onset of schizophrenia [7,8].
Endogenous retroviruses, both HERV-W and HERV-H,
were also reported in patients of multiple sclerosis and
other types of autoimmune diseases [9,10].
Several studies implied the GABA receptors in the
aetiology of schizophrenia. Besides the study by Mirnics
et al. [5] other groups also found the GABA receptor B1
gene (GABBR1) to be downregulated in schizophrenic
patients [3,11,12].
Several papers implicated the 6p22 chromosomal region
in schizophrenia, based on genetic studies of familial cases
and large cohorts [4,13]. A review outlined a long genomic
region to be associated with the disease, encompassing
25 Mb of the 6p genomic region in question [14].
However, several of the common variants implicated in
schizophrenia showing a significant association were not
associated with any particular genes [4]. This also leads us
to the question of genetic changes that are outside of the
coding region of protein-coding genes. This is becoming
ever more evident as less single nucleotide variants are
found to be associated with genetic diseases that affect the
protein sequence than found in regulatory regions [15].
However, only sporadic knowledge existed till now
regarding the regulatory regions of genes that mightis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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diseases. A recent publication has identified ~2.9 million
DNase I hypersensitive sites (DHSs), markers of regulatory
DNA in the human genome, based on the coexpression
patterns of the regions and known promoters of all human
protein-coding genes [16]. The authors did not investigate
if these regulatory elements are enhancers, silencers,
insulators or other types of regulators.
Findings
Here we analyzed these regulatory regions of the human
genome for the presence of the long terminal region (LTR)
of the human endogenous virus type W (HERV-W) as this
type of HERV was identified in patients with recent-onset
schizophrenia [7]. We used the LTR as query as opposed to
the full sequence of HERV-W because it is known to have
enhancer/promoter/regulatory functions [17].
Using the HERV-W long terminal repeat (LTR) as
query against the regulatory sequences identified in the
study of Thurman et al. [16] revealed a full-length match
in the regulatory region of GABBR1, the GABA receptor
B1 gene (Table 1). GABBR1 is located in the 6p22 chromo-
somal region that has been implicated in schizophrenia for
a long time. As HERVs, especially subtype W, are often
found to be differentially expressed in the brain of schizo-
phrenic patients [7], this brings up the possibility that theyTable 1 Regulatory regions for schizophrenia-related
genes (as annotated by Genecards [2]) that have a full or
partial match with the LTR of HERV-W
Gene list chr ltrstart ltrstop e-value Score
GABBR1 chr6 29526020 29526766 0.0 1042
MAPK10 chr4 86878290 86877559 0.0 834
MAPK10 chr4 86878341 86877841 1,00E-160 630
DLD chr7 107977734 107978228 0.0 706
NRCAM chr7 107977734 107978228 0.0 706
NR3C2 chr4 148920214 148920590 1,00E-115 464
ATM chr11 107851843 107852136 2,00E-106 430
SLC18A1 chr8 20016820 20017144 5,00E-83 344
SLC18A1 chr8 20017040 20017144 7,00E-12 82
FAAH chr1 46856820 46856990 2,00E-44 202
CDC25A chr3 48377262 48377349 1,00E-27 140
MAP4 chr3 48377349 48377262 1,00E-27 140
SHISA5 chr3 48377262 48377349 1,00E-27 140
MAP2 chr2 210171660 210171694 2,00E-05 58
ACTB chr7 5832898 5832925 0.003 50
The regulatory regions were taken from Thurman et al. [16]. The LTR sequence
ranges (ltrstart, ltrstop), evalues and scores were calculated using the Blastn
program [18]. A large fraction of the regulatory regions identified by Thurman
et al. [16] were associated with more than one gene and most genes were
also associated with more than one regulatory region.could trigger the downregulation of GABBR1 via its LTR
enhancer/regulator.
A full search with the HERV-W LTR as query identified
12 other genes with partial LTR matches overlapping
enhancer/regulatory sequences identified by [16], listed in
Table 1. Besides GABBR1, which had the strongest match
with the LTR sequence of HERV-W, several other
schizophrenia-related genes had a partial match. Of those,
NRCAM, the neural cell adhesion molecule gene has a
well-established association with schizophrenia. Barbeau
et al. found that its embryonic isoform was severely
decreased in the brain of schizophrenic patients [19].
Interpretation. Long terminal repeats (LTRs) of endogen-
ous viruses have long been known to act as enhancers/
silencers/regulators of gene expression. However, a lack of
comprehensive knowledge of regulatory regions associated
with their corresponding gene have been lacking till now.
As enhancers can be located hundreds of kilobases away
from their target gene, a purely computational approach
could not possibly identify such regions. The recent study
by Thurman et al. [16] made it possible for the first time to
analyze the regulatory regions by querying their sequences
with functional elements with known (or suspected)
pathogenic functionality.
What is the significance of the HERV-W sequences
present in the regulatory regions of genes implicated in
schizophrenia? Our hypothesis is that their overexpression
at the onset of the disease (triggered by an external factor
such as an exogenous virus or stress, etc.) leads to their
silencing (or downregulation) by hypermethylation.
Transposable element silencing as a consequence of DNA
methylation is a well-known phenomenon in mammalian
species as it is considered the defense system of the host
against its “intragenomic parasites”, as Yoder et al. calls
these elements [20]. In this model silencing genes with a
HERV in their regulatory region might be the collateral
damage, so to speak, brought upon by the host in its effort
to repress the transcription of the HERV-W endogenous
retroviruses, ultimately leading to schizophrenia.
Our finding of a full-length HERV-W LTR in the
regulatory region of the GABA receptor B1 gene
GABBR1 implicates it in a subset of cases of schizophrenia.
This is in accord with several lines of experimental
evidence, notably:
(i) The gene is in the 6p22 genomic region that has
been implicated most often in schizophrenia in
linkage disequlibrium studies [4,13].
(ii) Postmortem studies suggested that schizophrenia is
associated with deficits of GABA-mediated synaptic
transmission [21].
(iii) GABBR1 was found to be downregulated in several
postmortem studies of schizophrenic patients [5,12]
and also in autistic brains [22].
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silenced by hypermethylation is also supported by experi-
mental evidence, such as:
(iv)HERV-W RNAs tend to be expressed in the
cerebrospinal fluid of recent-onset schizophrenic
but not in chronic patients [7].
(v) Besides the decreased expression of GABBR1 and
that of the neuron adhesion molecule gene
(NRCAM), three other genes in Table 1 with the
highest scores were also found to be downregulated:
the dihydrolipoamide dehydrogenase (DLD) [23]
and the mineralocorticoid receptor (NR3C2) [24] in
the prefrontal cortex of schizophrenic patients,
whereas the mitogen-activated protein kinase 10
(MAPK10) was found to be silenced in several types
of cancer [25].
The significance of evidence (iv) is that the lack of
HERVs in chronic patients [7] might be due to silencing
by hypermethylation, activated by the overexpression of
HERV-W RNA at the onset of the disease. It is interesting
to note here that Karlsson et al. found recently an inverse
correlation between the levels of transcription of HERV-W
LTR intergenic elements and their downstream genes [9].
Our model is also supported by the recently observed
overexpression of DNA-methyltransferase 1 (DNMT1)
in GABAergic interneurons of schizophrenic brains,
apparently actively hypermethylating genes with roles in
schizophrenia [26]. Interestingly, one of the genes
hypermethylated by DNMT1 is reelin [27], which also
contains a HERV-W-like sequence (although not an LTR)
in its regulatory region (data not shown).Conclusion
Taken together, we provided a new hypothesis for the
cause of schizophrenia, surmising that the downregulation
of several genes containing a HERV-W LTR in their regula-
tory region might be brought upon by the host in its effort
to suppress the expression of the HERV-W sequences,
observed usually only at the onset of the disease. It must
be noted that our model can be applied to other types of
HERVs and other diseases as well. Notably, we also found
that one of the genes in our list, MAPK10 is silenced in
several types of cancer. Further studies of gene expression
and genome-wide methylation might provide a confirm-
ation (or refutal) of our hypothesis.
Abbreviations
HERV: Human Endogenous Retrovirus; LTR: Long Terminal Repeat;
DHS: DNase I hypersensitive site; GABA: Gamma-Aminobutyric Acid.
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Review by Sandor Pongor
The author presents a new hypothesis about the role a GABA receptor,
GABBR1 might play in the aetiology of schizophrenia. She bases her theory
on a new finding that identifies a HERV-W long terminal repeat in the
regulatory region of GABBR1. This is an interesting new theory that would
help explain how the ubiquitously present HERV-W elements in recent-onset
schizophrenics might contribute to the disease via a full-length LTR
regulating the expression of a GABA receptor gene. While, if true, the full
picture is probably more complex than stated here (the author herself cites
the staggering number of more than 1500 genes being involved in
schizophrenia), it is an intriguing theory that might be worthwhile to pursue
further, in the light of the fact that the aetiology of the disease is still not
known. The author may want to include a few ideas regarding how the
hypothesis can be tested.
Quality of written English: Acceptable
I thank Prof. Pongor for his favorable review and suggestions. I somewhat toned
down the language of the paper and geared it towards a multi-genic model. I
included a sentence at the end regarding experiments to test my hypothesis. It
is not easy, of course, as animal models are not very accurate, but the recent
advances in genome-wide methylation studies could provide an answer.
Review by Martijn Huynen
The manuscript by Hedi Hegyi argues that it explains the how HERV-W
elements play a role in Schizophrenia, based on a combination of observations
from the literature about links between Schizophrenia, the expression of HERV-
W retroviruses after the onset of Schizophrenia, differential expression of GABA
receptors in Schizophrenia, the genomic region that has classically been
associated with Schizophrenia (6p22.1) and the author’s own analysis of the
genome and the distribution of published DNAse I accessible sites over HERV-
W LTRs in Schizophrenia associated genes.
My main criticism is that most of the observations that the hypothesis is
based on are themselves hypothesis or associations rather than established
causal mechanisms. This makes choosing which evidence is relevant and
which is not hard to evaluate. In the genomics area there are so many data
sets available that one can be rather eclectic in deciding which ones to
choose. I am not accusing the author of doing that, but it is not clear to me
why which datasets were chosen. I think it is e.g. pointless to take as input a
list of 1600 genes potentially related to schizophrenia.
I thank Martijn Huynen for his thorough review and critical comments, I am
going to address them one by one.
I took out the considerations about the 1600 genes and the number of protein
binding partners as not very relevant to the main findings.
To my understanding, no causal relationships have been established between
GABA receptor expression and schizophrenia or between HERV-W retroviruses
and schizophrenia, or between any gene in 6p22.1 and schizophrenia.
No causal relationship has been established between schizophrenia and
anything yet. That is the point of my paper, to try to establish a causal
relationship between the HERVs and schizophrenia. I hope I made my case
stronger in this revised version.
At least one of these relationships is not even consistent: one study shows an
increased number of GABA receptors in the brain of schizophrenic patients,
while another shows a downregulation of the expression of the gene.
Good point. Digging up the evidence about the increased number of GABA
receptors made it clear that it was about the GABA A receptors, therefore I
removed it as immaterial to my arguments.
The author’s hypothesis, compelling as it may be, therewith appears thus to
be build on quicksand. It is not the first time that an analysis of genomics
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would like to see some solid mechanisms. Regarding mechanism: as I
understand from the literature, expression of HERV-W and other HERV
elements after the onset of Schizophrenia has been repeatedly observed. A
direct role of human endogeneous retroviruses in Schizophrenia has not
been established, so it is not clear to me which role needs to be explained.
It has not been established because nobody gave a satisfactory explanation yet.
That does not mean there is no causal relationship!
All in all I do find the conclusions of the manuscript not very tangible and
convincing. Lemma V of the discussion contains three “mights”. To me that
is two too many for a convincing hypothesis.
I took out Lemma V as it contained the uncertainty about the increase
(GABA A) as opposed to the decrease (GABA B) in the receptors as I explained
above. I think (and I hope you agree) my paper and arguments are much more
coherent in this revised version, as I was rethinking them and the paper evolved
considerably because of that.
Question:
The Thurman study measured DNAse I accessibility in 125 diverse cell and
tissue types. Which of these were chosen for the analysis in Table 1?
The Thurman study did not provide information about tissue types for this
particular dataset.
Editorial:
Why was only the HERV-W LTR chosen and not the whole genome, because
of their role in regulating gene expression? Could the author mention this
earlier in the manuscript and provide a solid reference?
Yes. I inserted now an appropriate reference.
synapse, not “synapsis”.
Corrected.
Quality of written English: Needs some language corrections before being
published.
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